Expression of an HBV PreS1 Fusion Protein in Escherichia coli

被引：0
|
作者：
金冬雁
曾庆
周园
侯云德
机构：
[1] Chinese Academy of Preventive Medicine.Beijing 100052
[2] PRC
[3] State Key Laboratory of Molecular Virologv and Generic Engineering
来源：
ChineseScienceBulletin | 1994年 / 01期
关键词：
hepatitis B virus (HBV) preS1 protein; expression of cloned genes; fusion protein; protein sequencing;
D O I：
暂无
中图分类号：
Q51 [蛋白质];
学科分类号：
071010 ; 081704 ;
摘要：
The large protein of the hepatitis B virus (HBV) envelope was subdivided intothe preSl region with 108-115 amino acids, the preS2 region with 55 amino acidsand the S region with 226 amino acids. It was believed that the preSl region cotainedthe hepatocyte attachment sites of the virus as well as multiple highly immunogenicT-cell and B-cell epitopes. The antibody response to the preSl peptide was also oneof the most important serological markers of HBV infection.
引用
收藏
页码：80 / 85
页数：6
相关论文
共 50 条
  • [41] Cloning and expression of the preS1 gene of hepatitis B virus in yeast cells
    Yin-Ying Lu
    Ke Li
    Jun Cheng
    Lin Wang
    Yan Liu
    Ling-Xia Zhang From the Gene Therapy Research Center
    Hepatobiliary & Pancreatic Diseases International, 2002, (02) : 238 - 242
  • [42] 抗HBV preS1嵌合抗体的真核表达及活性分析
    陈瑛炜
    罗文新
    王晋
    王明桥
    顾颖
    林亦伟
    张军
    夏宁邵
    中华微生物学和免疫学杂志, 2007, (02)
  • [43] NACA as a Potential Cellular Target of Hepatitis B Virus PreS1 Protein
    Dan Li
    Xiao Zhong Wang
    Jian Ding
    Jie-Ping Yu
    Digestive Diseases and Sciences, 2005, 50 : 1156 - 1160
  • [44] NACA as a potential cellular target of hepatitis B virus PreS1 protein
    Li, D
    Wang, XZ
    Ding, J
    Yu, JP
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (06) : 1156 - 1160
  • [45] A novel gene immunotherapy for chronic HBV and HDV: blocking viral entry by neutralizing PreS1 antibodies
    Frelin, L.
    Maravelia, P.
    Jagya, N.
    Verch, G.
    Ni, Y.
    Perez, N. C.
    Portoles, I.
    Urban, S.
    Saellberg, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 9 - 10
  • [46] A Novel Gene Immunotherapy for Chronic HBV and HDV: Blocking Viral Entry by Neutralizing PreS1 Antibodies
    Frelin, Lars
    Maravelia, Panagiota
    Jagya, Neetu
    Verch, Georg
    Ni, Yi
    Perez, Noelia Caro
    Portoles, Irene
    Urban, Stephan
    Saellberg, Matti
    MOLECULAR THERAPY, 2018, 26 (05) : 242 - 242
  • [47] Polymorphic analysis of bulevirtide sequence in PreS1 of large HBsAg across HBV genotypes A-H
    Mateo, Roberto
    Aeschbacher, Thomas
    Liu, Yang
    Xu, Simin
    Han, Bin
    Yazdi, Tahmineh
    Manhas, Savrina
    May, Lindsey
    Han, Dong
    Chang, Silvia
    Aryal, Rishi
    Martin, Ross
    Svarovskaia, Evguenia S.
    Mo, Hongmei
    JOURNAL OF HEPATOLOGY, 2022, 77 : S247 - S248
  • [48] HBV血清标志物、PreS1抗原与肝癌关系的研究
    姚晓艺
    唐少华
    徐令清
    湖南师范大学学报(医学版), 2006, (01) : 72 - 73
  • [49] TIMM29 interacts with hepatitis B virus preS1 to modulate the HBV life cycle
    Muriungi, Nelly Gakii
    Ueda, Keiji
    MICROBIOLOGY AND IMMUNOLOGY, 2020, 64 (12) : 792 - 809
  • [50] High-level soluble expression of hIGF-1 fusion protein in recombinant Escherichia coli
    Zhang, Danping
    Wei, Peilian
    Fan, Limei
    Lian, Jiazhang
    Huang, Lei
    Cai, Jin
    Xu, Zhinan
    PROCESS BIOCHEMISTRY, 2010, 45 (08) : 1401 - 1405
12345